Showing results (2351-2360 of 2,407) with videos related to

Sort By:
Pageof 241
Future Medicinal Chemistry|February 13, 2024
Novel sulfonamide derivatives as a tool to combat methicillin-resistant Staphylococcus aureusMartin Krátký
Future Medicinal Chemistry|January 30, 2024
Investigations of new N-substituted pyrazoles as anti-inflammatory and analgesic agents having COX inhibitory activityMona F Said, Riham F George, Walid Fayed, et al.
Future Medicinal Chemistry|August 2, 2023
Discovery of new thieno[2,3-d]pyrimidines as EGFR tyrosine kinase inhibitors for cancer treatmentEman A Sobh, Mohammed A Dahab, Eslam B Elkaeed, et al.
Future Medicinal Chemistry|July 26, 2023
New thiouracil derivatives as histone deacetylase inhibitors and apoptosis inducers: design, synthesis and anticancer evaluationOmnia R Elbatrawy, Moshira A El Deeb, Mohamed Hagras, et al.
Future Medicinal Chemistry|August 8, 2023
Novel hydroxy- and amidino-substituted benzimidazoles and benzothiazoles as antibacterial and antiproliferative agentsAnja Beč, Livio Racané, Teo Tomić, et al.
Future Medicinal Chemistry|July 28, 2023
One-pot multicomponent synthesis of novel pyridine derivatives for antidiabetic and antiproliferative activitiesNusrat Shafiq, Nabeel Shahzad, Fatima Rida, et al.
Future Medicinal Chemistry|March 24, 2026
Recent advances in the design and development of small molecules targeting the TLR4 signaling pathwayMuhammad Ishfaq, Muhammad Shahab, Guosong Jiang
Future Medicinal Chemistry|March 26, 2026
Design, synthesis, and biological evaluation of disubstituted thiazolidinedione derivatives as pancreatic lipase inhibitors for the management of obesityMhd Shabbu Khan, Rakesh Khator, Nisha Yadav, et al.
Future Medicinal Chemistry|March 19, 2026
Rational design and biological investigation of benzylidene-substituted pyrazolo[3,4-b]pyridine derivatives as novel PIM-1 kinase inhibitors with anticancer potentialAastha Singh, Subhadip Maity, Priya Devi, et al.
Future Medicinal Chemistry|April 17, 2024
Synthesis, in vitro and in silico anticancer evaluation of novel pyridin-2-yl estra-1,3,5(10)-triene derivativesMilica Z Stevanović, Sofija S Bekić, Edward T Petri, et al.
Pageof 241